TABLE 3.
Comparison of microRNA-155 expression levels across demographic and laboratory subgroups (n = 80).
| Variables | microRNA-155 (n = 80) | ||||
|---|---|---|---|---|---|
| n | Median (Q1, Q3) a | Minimum | Maximum | P-value | |
| Gender Female Male |
36 44 |
0.50 (0.25, 0.74) 0.45 (0.31, 1.49) |
0.11 0.11 |
10.53 10.53 |
0.006 b |
| Age group (years) 8–12 13–17 |
32 48 |
0.50 (0.32, 3.19) 0.47 (0.28, 0.75) |
0.12 0.11 |
10.46 10.40 |
0.576 |
| Residency Rural Urban |
47 33 |
0.55 (0.30, 1.16) 0.47 (0.31, 0.74) |
0.11 0.11 |
10.53 9.85 |
0.594 |
| EVBIgM Negative Positive |
41 39 |
0.43 (0.29, 0.61) 1.12 (0.32, 7.22) |
0.11 0.11 |
0.77 10.53 |
0.004 |
| EVBIgG Negative Positive |
66 14 |
0.51 (0.30, 0.77) 0.39 (0.17, 3.19) |
0.11 0.12 |
10.46 10.53 |
0.785 |
| Interleukin-18 Negative Positive |
67 13 |
0.44 (0.28, 0.72) 3.98 (0.67, 7.21) |
0.11 0.11 |
10.46 10.53 |
0.008 |
| Interleukin-32 Negative Positive |
41 39 |
0.44 (0.30, 0.62) 0.77 (0.32, 7.20) |
0.11 0.11 |
10.40 10.53 |
0.031 |
a
Q1 is quantile one and, Q3 is quantile three.
b
P value obtained from Mann-Whitney test.